Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)

NCT01256684 is registered in ClinicalTrials.gov with EndoCeutics Inc. as lead sponsor.

NCT NCT01256684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01256684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Lead sponsor
EndoCeutics Inc.
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2010
Completion date
November 30, 2011
Enrollment
255 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

vaginal atrophy